Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

New indication claimed for EPO

Sep. 20, 1996

Wakamoto claims diclofenac eyedrop formulation

Sep. 20, 1996

Pfizer describes anticancer application for known antidepressant

Sep. 20, 1996

Taxotere-doxorubicin com0bination as first-line treatment of advanced breast cancer

Sep. 20, 1996

CI-958 for treatment of prostate cancer

Sep. 20, 1996

Further approval recommended for Novantrone

Sep. 20, 1996

New formulation of ciclosporin

Sep. 20, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Antibacterial compositions for MRSA

Sep. 20, 1996

A safe, effective and economical contraceptive method

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...